Lexeo TherapeuticsLXEO
13F holders, Q2 2024 (June 30)60holders +6
13new positions
9sold out
4famous investors
$16.04avg. 13F price*
At the end of Q2 2024, 60 institutions reported holding Lexeo Therapeutics Inc. (LXEO) in their 13F filings, up 6 from Q1 2024. 13 opened new positions and 9 sold out. The largest holders were Eventide Asset Management, LLC ($54.0M), Janus Henderson Group PLC ($50.7M) and Adage Capital Partners Gp, L.L.C. ($41.7M). 4 famous investors held it, including Daniel Sundheim (0.7% of D1 Capital Partners's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio).
- Company
- Lexeo Therapeutics Inc.
- CUSIP
- 52886X107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $4.2M |
| Exits | 9 | $4.5M |
All 13F filers, Q1 2024 → Q2 2024: 4,744,648 shares bought and 1,297,712 shares sold, net +3,446,936 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 60 holders
| Eventide Asset Management, LLC | 0.93% | No change | 3,369,147 | $54.0M |
| Janus Henderson Group PLC | 0.03% | Add +24.5% | 3,163,992 | $50.7M |
| Adage Capital Partners Gp, L.L.C. | 0.08% | Add +96.4% | 2,597,736 | $41.7M |
| Citadel Advisors | 0.04% | Add +2.2% | 2,558,611 | $41.0M |
| D1 Capital Partners | 0.68% | No change | 2,506,607 | $40.2M |
| Omega Fund Management, LLC | 28.00% | No change | 2,355,904 | $37.8M |
| Novo Holdings A/S | 1.25% | Reduce -11.5% | 1,450,500 | $23.3M |
| Braidwell LP | 1.13% | Add +4.5% | 1,382,481 | $22.2M |
| Vestal Point Capital, LP | 1.00% | Add +380.0% | 840,000 | $13.5M |
| Woodline Partners LP | 0.13% | Add +6738.2% | 824,074 | $13.2M |
| Blackstone Inc. | 0.06% | Add +15.8% | 805,757 | $12.9M |
| BlackRock Inc. | 0.00% | Add +19.4% | 791,584 | $12.7M |
| Ra Capital Management, L.P. | 0.14% | Add +1.8% | 672,712 | $10.8M |
| Vanguard Group Inc. | 0.00% | Add +30.8% | 629,919 | $10.1M |
| Artal Group S.A. | 0.25% | Reduce -24.7% | 603,435 | $9.7M |
| Laurion Capital Management LP | 0.24% | Reduce -0.1% | 453,582 | $7.3M |
| Verition Fund Management LLC | 0.06% | Add +592.6% | 421,392 | $6.8M |
| Geode Capital Management, LLC | 0.00% | Add +50.0% | 296,612 | $4.8M |
| State Street Corp. | 0.00% | Add +74.9% | 196,272 | $3.1M |
| Tudor Investment Corporation | 0.02% | New | 132,187 | $2.1M |
| Northern Trust Corp. | 0.00% | Add +15.6% | 94,907 | $1.5M |
| Polar Asset Management Partners Inc. | 0.04% | New | 65,300 | $1.0M |
| Millennium Management | 0.00% | Reduce -93.7% | 37,466 | $601K |
| Bank of New York Mellon Corp | 0.00% | Add +12.3% | 31,806 | $510K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +12.8% | 30,861 | $495K |
| Goldman Sachs Group Inc. | 0.00% | Add +14.0% | 26,853 | $431K |
| Jane Street Group, LLC | 0.00% | Reduce -33.0% | 26,759 | $429K |
| Wellington Management Group LLP | 0.00% | New | 22,101 | $355K |
| Barclays PLC | 0.00% | Reduce -16.5% | 19,153 | $307K |
| Nuveen Asset Management, LLC | 0.00% | Add +35.7% | 18,293 | $293K |
| Caxton Corp. | 1.45% | Add +73.0% | 17,851 | $286K |
| Bank of America Corp. | 0.00% | Add +177.9% | 14,651 | $235K |
| Franklin Resources Inc. | 0.00% | New | 14,035 | $225K |
| Rhumbline Advisers | 0.00% | Add +37.3% | 13,357 | $214K |
| Morgan Stanley | 0.00% | Reduce -9.2% | 12,663 | $203K |
| Citigroup Inc. | 0.00% | Reduce -76.5% | 11,545 | $185K |
| Alliancebernstein L.P. | 0.00% | New | 10,750 | $172K |
| EntryPoint Capital, LLC | 0.08% | New | 10,542 | $169K |
| MetLife Investment Management, LLC | 0.00% | Add +10.3% | 6,420 | $103K |
| Corebridge Financial, Inc. | 0.00% | — | 5,507 | $88K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | — | 4,881 | $78K |
| Deutsche Bank AG | 0.00% | New | 4,560 | $73K |
| JPMorgan Chase & Co. | 0.00% | Reduce -26.7% | 4,363 | $70K |
| New York State Common Retirement Fund | 0.00% | Add +2.1% | 4,187 | $67K |
| Wells Fargo & Company | 0.00% | Reduce -0.8% | 3,341 | $54K |
| UBS Group AG | 0.00% | Reduce -69.8% | 3,129 | $50K |
| BNP Paribas Financial Markets | 0.00% | Reduce -59.2% | 1,950 | $31K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +210.7% | 1,575 | $25K |
| ADAR1 Capital Management, LLC | 0.00% | New | 1,300 | $21K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 1,023 | $16K |
| Legal & General Group Plc | 0.00% | Add +17.0% | 1,010 | $16K |
| Royal Bank of Canada | 0.00% | Add +175.5% | 967 | $15K |
| California State Teachers Retirement System | 0.00% | Reduce -28.0% | 742 | $12K |
| Amalgamated Bank | 0.00% | No change | 623 | $10K |
| FMR LLC | 0.00% | Add +938.5% | 135 | $2K |
| Nisa Investment Advisors, LLC | 0.00% | New | 32 | $513 |
| GAMMA Investing LLC | 0.00% | New | 14 | $225 |
| Arax Advisory Partners | 0.00% | New | 12 | $193 |
| Lazard Asset Management LLC | 0.00% | New | 33 | $0 |
| Cwm, LLC | 0.00% | New | 16 | $0 |
"% of holder's portfolio" is LXEO's weight in each manager's 13F, not the share of Lexeo Therapeutics Inc. the manager owns.